Stephanie received her Ph.D. in Chemistry from the University of Windsor (Ontario, Canada) with Prof. Charles L.B. Macdonald in 2017. There, she specialized in crystallography and organophosphorus transformations. After...
By Dr. David J. Lamberto, Merck The crystallization of an active pharmaceutical ingredient (API) from ethanol and water exhibited non-typical behavior relative to the formation of the desired three-dimensional...
David J. Lamberto received his bachelor’s degree in chemical engineering from the University of Arizona before pursuing his Ph.D. and master’s degrees in chemical engineering from Rutgers University. His...
Dr. Christopher Burcham is an AIChE Fellow and an Executive Director in the Synthetic Molecule Design and Development (SMDD) Department at Eli Lilly & Company. Chris leads the Crystallization and...
Dr. Fredrik Nordstrom is the head of the Solid State Chemistry group and global Crystallization Network at Boehringer-Ingelheim and is located in Ridgefield, CT. His teams are responsible for...
By Dr. Dimitrios Zarkadas, Ph.D. Director, Merck & Co Control of physical attributes of amorphous Active Pharmaceutical Ingredients (APIs) can be challenging due to processability issues, their wide variation...
Dr. Dimitrios Zarkadas has 20 years of experience in API development, commercialization and lifecycle management. He is currently leading API lifecycle management and development activities for the Merck Animal...
By Dr. Shuang Chen, Ph.D. Senior Principal Scientist, AbbVie In recent years, more and more structurally diverse and complex molecules have been developed to tackle difficult but attractive drug...
